Article

[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].

Univ.-Klinik für Kinder und Jugendheilkunde, Austria,
Wiener klinische Wochenschrift (impact factor: 0.81). 10/2009; 121(19-20):648-60. DOI:10.1007/s00508-009-1258-8 pp.648-60
Source: PubMed

ABSTRACT A pediatric consensus report on allergen-specific immunotherapy for children and adolescents is presented for Austria. Products on the market in Austria are presented and categorised according to studies performed on the target population of children and adolescents, their effectiveness and indication. In general, more clinical studies on children and adolescents are mandatory for most of the available allergen-specific immunotherapeutics. In addition, the use of allergen-specific immunotherapy in general should be promoted as the exclusive treatment with long-lasting effects in type I allergies in particular in children.

0 0
 · 
0 Bookmarks
 · 
44 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

allergen-specific immunotherapy
 
Austria
 
available allergen-specific immunotherapeutics
 
children
 
clinical studies
 
exclusive treatment
 
long-lasting effects
 
pediatric consensus report
 
target population